CN101181433B - Chinese medicine medicament for curing pterygium - Google Patents
Chinese medicine medicament for curing pterygium Download PDFInfo
- Publication number
- CN101181433B CN101181433B CN2007101136530A CN200710113653A CN101181433B CN 101181433 B CN101181433 B CN 101181433B CN 2007101136530 A CN2007101136530 A CN 2007101136530A CN 200710113653 A CN200710113653 A CN 200710113653A CN 101181433 B CN101181433 B CN 101181433B
- Authority
- CN
- China
- Prior art keywords
- medicine
- powder
- pterygium
- ground
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a traditional Chinese medicine drug which cures pterygium. The invention is thin powder separating granule produced by using rhizoma coptidis, radix scutellariae, mast, pipewort, muskiness, equisetum, rhubarb, cuttlefish bone, cicada ecdysis and periostracum serpentis as raw materials, through decocting, drying, grinding to powder and delicately grinding. The invention chooses purely natural Chinese medicine as the raw materials and each component accords with the prescription of medicine politics and law; the invention utilizes the comprehensive functions of varied Chinese medicines and has special effect on the pterygium. The invention chooses 56 examples of patients suffering 62-mesh pterygium through clinic observation and the total cure rate reaches 100 percent.
Description
Technical field the invention belongs to the Chinese medicine technical field of pharmaceuticals, is specifically related to the pterygial Chinese medicine medicine of a kind of treatment.
The background technology pterygium is the comparatively common eye surface diseases of ophthalmology, is ophthalmology common disease, frequently-occurring disease, sees with middle-aged and elderly people and outwork person, if bulbar conjunctiva polyp is invaded and the cornea lesser ring of Merkel can affect one's power of vision more.Patient suffers from eye often a puckery sense of itching, and the progressive stage bulbar conjunctiva polyp puckery sense of itching increases the weight of, and suffers from bloodshot eyes, sheds tears, gives birth to gum, influences patient's quality of life.General good sending out in nasal side fissura palpebrae portion also has nose temporo bilateral to send out the patient.Its definite etiology unknown, the inducement that the ill effect of environmental stimuli may take place, develop for it.To its treatment is a more thorny clinically difficult problem.Excision is the most frequently used method of this disease of treatment, but the recurrence after operation rate is higher, can reach the effect that the traditional operation method of 25%-70% is difficult to reach healing.The postoperative recurrence person can produce symblepharon in various degree, and scar tissue is extensive, even influences the eyeball rotation.Pterygial traditional Chinese medical science name is called pterygium, thinks that its etiology and pathogenesis mostly is due to " heat stagnation stasis, venation is retarded by silt ".Treat this disease at present based on excision, but relapse rate is higher, surgery cost is higher relatively, and the outpatients mental state burden is bigger.
Summary of the invention the purpose of this invention is to provide the pterygial Chinese medicine medicine of a kind of easy to use, cheap treatment.
Solution of the present invention is based on motherland's medical science to pterygial pathogenetic understanding and Therapeutic Principle, with reference to ancient, modern pharmacological research achievement, from motherland's medical treasure-house, filter out that collateral dredging is invigorated blood circulation, the natural Chinese medicine of strengthening vital QI to eliminate pathogenic factors, by the theory of Chinese medical science prescription, skim the cream off milk, pterygium is had the effect of healing.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Rhizoma Coptidis 6, Radix Scutellariae 9, Fructus Gardeniae 10, Flos Eriocauli 10, Moschus 1, Herba Equiseti Hiemalis 10, Radix Et Rhizoma Rhei 3, Endoconcha Sepiae 10, Periostracum Cicadae 3, Periostracum Serpentis 1;
Above-mentioned each component is made Chinese powder medicine, finishes by following step successively:
1) decocts: the Radix Scutellariae in the said medicine, Rhizoma Coptidis, Fructus Gardeniae, Radix Et Rhizoma Rhei, Flos Eriocauli and Herba Equiseti Hiemalis, put into marmite or stainless-steel pan, add water by 1: 2 of medicine total amount, slow fire boiling was boiled back 20 minutes, and medicinal liquid is leached, adding hydrology fire by 1: 1 of medicine total amount again decocts, boiled back 20 minutes, medicinal liquid is leached, waste stays liquid;
2) oven dry is ground into powder: with behind twice filtrate mixing, the Endoconcha Sepiae, Periostracum Cicadae, the Periostracum Serpentis slow fire that add in the said medicine are fried in shallow oil slowly again, and the oven dry of anhydrous back is ground into powder;
3) system powder: then Moschus is added in the medicine after oven dry is ground into powder, carefully be ground into fine powder powder again, promptly get Chinese powder medicine of the present invention.
Chinese medicine drug powder of the present invention is named and is " Nu dissipation ".
Radix Scutellariae in the medicine of the present invention, bitter in the mouth is cold, returns lung, gallbladder, stomach, large intestine channel, has the effect of heat clearing and damp drying, eliminating fire and detoxication, energy antiinflammatory, antiallergic, antithrombotic formation; Rhizoma Coptidis, bitter in the mouth, cold, GUIXIN, liver, stomach, large intestine channel have the effect of heat clearing and damp drying, eliminating fire and detoxication, can be antibiotic, antiviral, enhance immunity function; Fructus Gardeniae, bitter in the mouth, cold, GUIXIN, liver, lung, stomach warp have the effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, cooling blood for hemostasis; Radix Et Rhizoma Rhei, bitter in the mouth, cold is returned spleen, stomach, large intestine, liver, pericardium channel, has the effect of capturing stagnant, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation, promoting the function of the gallbladder to alleviate jaundice; Flos Eriocauli, acrid in the mouth, sweet, flat is returned liver, lung meridian, has the effect of wind-dispelling heat-dissipating, improving acuity of vision and removing nebula; The Herba Equiseti Hiemalis, sweet in the mouth, hardship, flat are returned lung, Liver Channel, have diffusing wind heat, move back corneal nebula, the effect of hemostasis; Endoconcha Sepiae, salty in the mouth, puckery, tepor are returned liver, kidney channel, have the effect that astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, relieving gastric hyperacidity to alleviate stomachache, removing dampness are held back skin ulcer; Periostracum Serpentis, nature and flavor are sweet, salty, flat, have dispel the wind, the effect of arresting convulsion, antipruritic, nebula removing; Periostracum Cicadae, sweet in the mouth, cold is returned lung, Liver Channel, has that dispelling wind and heat pathogens, rash are antipruritic, an effect of improving acuity of vision and removing nebula, relieving spasm by subduing liver-wind; Moschus, acrid in the mouth, temperature, GUIXIN, spleen channel have the effect of the refreshment of having one's ideas straightened out, blood circulation promoting and dispersing pathogen accumulation, and antiinflammatory action is arranged, and vascular permeability increase phase, leukoplania phase and granulation formation phase three phases to the inflammation pathological process all have inhibitory action.Above-mentioned all medicines have specially good effect through reasonable compatibility to pterygium.
The clinical use result of drug powder of the present invention " Nu dissipation " shows that following advantage is arranged:
The present invention selects the natural Chinese medicines raw material for use, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of, and pterygium is had specially good effect.
For showing the curative effect of Chinese medicine medicine decoction of the present invention " resolving depression soup ", the present invention selects 62 pterygium patients of 56 examples through clinical observation, and total cure rate reaches 100%.
Typical clinical case particulars is as follows:
Go to a doctor in 62 of pterygium patient 56 examples of my institute, 23 of wherein male 21 examples from year October in February, 2004 to 2007; 39 of woman's 35 examples.Age 32-71 year, average 48.6 years old.Wherein, resting stage bulbar conjunctiva polyp 43 examples, 48; Progressive stage 14 of bulbar conjunctiva polyp 13 examples; Pterygium is invaded and 18 of following person's 16 examples of cornea 1mm; It is above and do not reach lesser ring of Merkel cornea person 36 examples, 40 to invade cornea 1mm; 4 examples are arranged, and 4 pterygium heads are invaded and the lesser ring of Merkel cornea.
1, standard by stages
(1) resting stage bulbar conjunctiva polyp, three ones of head and neck bodies are clear, head is thinner, has stretched in the film lesser ring of Merkel or has approached lesser ring of Merkel, blood vessel is fuzzy to attenuate, blood fortune is interrupted; (2) carry out the phase bulbar conjunctiva polyp, the part is congestion and edema repeatedly, extends the cornea end and is the plumpness projection, and abundant vessel invasion is arranged, and each sign is unclear; (3) initial phase bulbar conjunctiva polyp, contrafluxion is the strong protuberance in island, exposes to the corneosclera end; (4) recurrent bulbar conjunctiva polyp, under the stimulation of external force, hyperemia increases the weight of repeatedly, the disorder of mucosa level, and hypertrophy adhesion constantly, this phase forms huge bulbar conjunctiva polyp easily.
2, Therapeutic Method
Dip in the eye dripping rod and to get a little Nu dissipation powder, put the fissura palpebrae in the bulbar conjunctiva polyp district, this moment, patient had the intraocular foreign body sense, and sand is puckery, shed tears, and advised patient to close order number minute, and the puckery symptom of shedding tears of sand just can be alleviated.Patient can carefully open eyes, and tries to rotate eyeball.Medicated powder can be gathered in corner of the eyes portion bulbar conjunctiva polyp and went out this moment, dipped in out with cotton swab or gauze and got final product every day 2-3 time.
3, points for attention
All patients the puckery symptom of shedding tears of eye sand all can occur suffering from after with Nu dissipation powder eye dripping, this be medicine and normal reaction.At this moment, do not rub one's eyes, in order to avoid cause corneal abrasion with hands.Only need whole body to loosen, close one's eyes gently, treat tear after fissura palpebrae flows out, suffering from the puckery symptom of shedding tears of eye sand can alleviate.Suffer from eye if during, should not use this medicine with actute infection inflammation and keratopathy.
4, curative effect assessment
Cure: pterygium disappears fully, and it is just round that cornea recovers, or companion's bulbar conjunctiva polyp head cornea leaves nebula; Effectively: the pterygium attenuation of disappearing, blood vessel reduces, attenuates; Invalid: pterygium no change or increase the weight of.
5, result
Among 62 pterygium patients of 56 examples, 59 healings of 54 examples are arranged, 3 of effective 2 examples, there is not the patient of recovery from illness to trace it to its cause, be can not the normal point medicament for the eyes, cause therapeutic effect to reduce, after do ideological work and extended treatment time owing to the reason of patient work and thought aspect, 3 are all obtained healing, and total cure rate reaches 100%.
6, conclusion
Pterygial patient therapeutic purposes untoward reaction in addition all do not occur during the treatment pterygium that dissipates with Nu, its safety, and effectiveness waits further observation.Can no matter Nu dissipates become the pterygial prefered method of treatment, for the treatment pterygium provides a kind of new method, provides a kind of new approaches after all.
The specific embodiment
Take by weighing raw material (gram) by following proportioning: Rhizoma Coptidis 6, Radix Scutellariae 9, Fructus Gardeniae 10, Flos Eriocauli 10, Moschus 1, Herba Equiseti Hiemalis 10, Radix Et Rhizoma Rhei 3, Endoconcha Sepiae 10, Periostracum Cicadae 3, Periostracum Serpentis 1;
Above-mentioned each component is made Chinese powder medicine, finishes by following step successively:
1) decocts: the Radix Scutellariae in the said medicine, Rhizoma Coptidis, Fructus Gardeniae, Radix Et Rhizoma Rhei, Flos Eriocauli and Herba Equiseti Hiemalis, put into marmite or stainless-steel pan, add water by 1: 2 of medicine total amount, slow fire boiling was boiled back 20 minutes, and medicinal liquid is leached, adding hydrology fire by 1: 1 of medicine total amount again decocts, boiled back 20 minutes, medicinal liquid is leached, waste stays liquid;
2) oven dry is ground into powder: with behind twice filtrate mixing, the Endoconcha Sepiae, Periostracum Cicadae, the Periostracum Serpentis slow fire that add in the said medicine are fried in shallow oil slowly again, and the oven dry of anhydrous back is ground into powder;
3) system powder: then Moschus is added in the medicine after oven dry is ground into powder, carefully be ground into fine powder powder again, promptly get Chinese powder medicine of the present invention.
Claims (1)
1. the pterygial Chinese medicine medicine of treatment is characterized in that it is the medicament of being made by the following weight proportion raw material: Rhizoma Coptidis 6, Radix Scutellariae 9, Fructus Gardeniae 10, Flos Eriocauli 10, Moschus 1, Herba Equiseti Hiemalis 10, Radix Et Rhizoma Rhei 3, Endoconcha Sepiae 10, Periostracum Cicadae 3, Periostracum Serpentis 1; Its preparation method is finished by following step successively: 1) decoct: with the Radix Scutellariae in the said medicine, Rhizoma Coptidis, Fructus Gardeniae, Radix Et Rhizoma Rhei, Flos Eriocauli and Herba Equiseti Hiemalis, put into marmite or stainless-steel pan, add water by 1: 2 of medicine total amount, slow fire boiling was boiled back 20 minutes, and medicinal liquid is leached, adding hydrology fire by 1: 1 of medicine total amount again decocts, boiled back 20 minutes, medicinal liquid is leached, waste stays liquid; 2) oven dry is ground into powder: with behind twice filtrate mixing, the Endoconcha Sepiae, Periostracum Cicadae, the Periostracum Serpentis slow fire that add in the said medicine are fried in shallow oil slowly again, and the oven dry of anhydrous back is ground into powder; 3) system powder: then Moschus is added in the medicine after oven dry is ground into powder, carefully be ground into fine powder powder again.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101136530A CN101181433B (en) | 2007-11-16 | 2007-11-16 | Chinese medicine medicament for curing pterygium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101136530A CN101181433B (en) | 2007-11-16 | 2007-11-16 | Chinese medicine medicament for curing pterygium |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101181433A CN101181433A (en) | 2008-05-21 |
CN101181433B true CN101181433B (en) | 2010-09-08 |
Family
ID=39446945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101136530A Expired - Fee Related CN101181433B (en) | 2007-11-16 | 2007-11-16 | Chinese medicine medicament for curing pterygium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101181433B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104207123A (en) * | 2014-08-21 | 2014-12-17 | 席安胜 | Dietary therapy formula for treating pterygium |
CN105030892A (en) * | 2015-08-25 | 2015-11-11 | 何萍萍 | Traditional Chinese medicine for treating pterygium |
CN106822788A (en) * | 2017-03-02 | 2017-06-13 | 董新芳 | It is a kind of to treat pteryium medicine and preparation method thereof |
-
2007
- 2007-11-16 CN CN2007101136530A patent/CN101181433B/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
李荣麟.《中西医结合治疗翼状胬肉19 例》.《四川中医》.2006,第24卷(第4期),94. * |
Also Published As
Publication number | Publication date |
---|---|
CN101181433A (en) | 2008-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631593B (en) | Preparation method of traditional Chinese medicine lotion for treating oedema lymphangitis | |
CN103006979A (en) | Chinese medicinal composition for treating nephrotic edema | |
CN102178903B (en) | Method for preparing traditional Chinese medicine for treating acute pancreatitis caused by overeating greasy food | |
CN102631530B (en) | Preparation method for traditional Chinese medicine wash lotion for treating itching type acute lymphangitis | |
CN101181433B (en) | Chinese medicine medicament for curing pterygium | |
CN103961587A (en) | Traditional Chinese medicinal preparation for treating radiographic contrast nephropathy and preparation method thereof | |
CN102380052B (en) | Method for preparing traditional Chinese medicine lotion for treating Qi- Yin deficiency bedsore | |
CN104666689A (en) | Medicine for treating hypertension | |
CN100431573C (en) | Medicine for treating aurigo | |
CN102631573B (en) | Preparation method of traditional Chinese medicinal lotion for treating dark urine type acute lymphangitis | |
CN103054979A (en) | Traditional Chinese medical formula for treating neonatal jaundice | |
CN102380010A (en) | Traditional Chinese medicine formula for treating idiopathic edema | |
CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
CN102813771A (en) | Preparation method of traditional Chinese medicine for treating hydroncus type acute glomerulonephritis | |
CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
CN102793866B (en) | Preparation method for traditional Chinese medicine used for treatment of feet oedema type acute glomerulonephritis | |
CN102327532B (en) | Capsule for treating rheumatism and rheumatoid arthritis | |
CN105055764A (en) | Medicine for treating chronic angle-closure glaucoma | |
CN102805853B (en) | Preparation method of traditional Chinese medicine for treating proteinuria type acute glomerulonephritis | |
CN103272128A (en) | Preparation method of traditional Chinese medicine for treating constipation type acute glomerulonephritis | |
CN104383025B (en) | Traditional Chinese medicine for treating chronic rheumatic heart diseases | |
CN102805852B (en) | Preparation method of traditional Chinese medicine for treating fever type acute glomerulonephritis | |
CN104435152A (en) | Traditional Chinese medicine agent with functions of tranquilizing and allaying excitement for treating stage I of hypertension and preparation method | |
CN102813846B (en) | Preparation method of traditional Chinese medicine for treating high fat-type acute glomerulonephritis | |
CN103585431A (en) | Traditional Chinese medicine composition for curing type I diabetes mellitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 Termination date: 20111116 |